Desenvolvimento de tromboembolismo venoso e seu impacto em adultos hospitalizados com covid-19: revisão sistemática rápida
Development of venous thromboembolism and its impact on hospitalized adults with covid-19: rapid systematic review
Andressa Pereira Rocha; João Gabriel Sanchez
Resumo
Palavras-chave
Abstract
The association between COVID-19 and coagulation disorders has been discussed since the onset of the pandemic. Four years into the pandemic, it is crucial to organize the findings and evidence accumulated thus far. The objective of this study was to review and synthesize the available scientific evidence regarding the relationship between COVID-19 and development of venous thromboembolism (VTE). A rapid systematic review was conducted by searching two electronic databases, selecting systematic review articles that assessed the association between COVID-19 and development of VTE, such as deep vein thrombosis (DVT) or pulmonary embolism (PE). The studies indicated that hospitalized COVID-19 patients are at greater risk of developing VTE, especially those admitted to intensive care units (ICUs). Elevated D-dimer levels and male gender were also associated with increased risks.
Keywords
References
1 Carvalho ACS, Barros LSA, Tenório ECPT, Lopes TP, Lopes LP, Cruz CM. Moduladores de coagulação alterados comprometem os pacientes infectados com COVID-19. Braz J Hea Rev. 2020;3(5):116624-44.
2 Ali MAM, Spinler AS. COVID-19 and thrombosis: From bench to bedside. Trends Cardiovasc Med. 2021;31(3):143-60.
3 Albricker ACL, Freire CMV, Santos SN, et al. Diretriz conjunta sobre tromboembolismo venoso: 2022. Arq Bras Cardiol. 2022;118(4):797-857.
4 Guyton AC, Hall ME, Hall JE. Parte 4: circulação. In: Hall JE, editor. Tratado de fisiologia médica. Rio de Janeiro: Elsevier; 2021. p. 45-53.
5 Nascimento CR, Santos JM, Brito SBP, Tenório PP. Quais são os mecanismos celulares relacionados aos eventos tromboembólicos em pacientes com covid-19? J Vasc Bras. 2021;20:e20210020.
6 Sousa MC, Santana TR, Oliveira ACP, Ferreira FSB, Xavier FD. Covid-19 e trombose. Rev Bras Med. 2021 [citado 2023 set 5];58:1-7.
7 Rodrigues BA, Nunes CP. Covid-19 e tromboembolismo pulmonar. Rev Fac Med Teres. 2021 [citado 2023 set 5];5(1):1-6.
8 Menezes AG, Sabadini T, Bueno SM. Tromboembolismo na covid-19. Rev Corpus Hippocraticum. 2022 [citado 2023 set 5];1(1):1-7.
9 Hendarto H, Akbar FN, Buwono PW, et al. Efficacy of therapeutic-dose heparin for severe covid-19 patients at covid-19 Emergency Hospital Jakarta. J Infect Dev Ctries. 2024;18(7):1002-9.
10 Higgins JPT, Thomas J, Chandler J, et al. editores. Cochrane handbook for systematic reviews of interventions. New York: Cochrane; 2023.
11 Haby MM, Chapman E, Clark R, Barreto J, Reveiz L, Lavis JN. What are the best methodologies for rapid reviews of the research evidence for evidence-informed decision making in health policy and practice: a rapid review. Health Res Policy Syst. 2016;14(1):83.
12 Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(71):n71.
13 Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.
14 Rocha AP, Silva MAO, Yamaguti ST, Sanchez JG. Desenvolvimento de distúrbios de coagulação em adultos hospitalizados com covid-19: protocol de revisão sistemática rápida. Geneva: Zenodo; 2023.
15 Ouzzani M, Hammady HM, Fedorowicz Z, Elmagarmid A. Rayyan: a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.
16 Wells PS, Hirsh J, Anderson DR, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet. 1995;345(8961):1326-30.
17 Mota CS, Jesus APS, Veiga IN. Covid-19 and its correlation with thromboembolic and cardiovascular events: a systematic review. J Health Sci. 2022;24(1):52-6.
18 Maitra S, Baidya DK, Bhattacharjee S, Anand RK, Ray BR. Epidemiology of venous thromboembolism in SARS-CoV-2 infected patients: a systematic review and meta-analysis. medRxiv. 2020.
19 Henrina J, Santosa Putra IC, Cahyadi I, Hadi Gunawan HF, Cahyadi A, Suciadi LP. Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for covid-19: systematic review and meta-analysis. medRxiv. 2020.
20 Suh YJ, Hong H, Ohana M, et al. Pulmonary embolism and deep vein thrombosis in covid-19: a systematic review and meta-analysis. Radiology. 2021;298(2):E70-80.
21 Kollias A, Kyriakoulis KG, Lagou S, Kontopantelis E, Stergiou GS, Syrigos K. Venous thromboembolism in covid-19: a systematic review and meta-analysis. Vasc Med. 2021;26(4):415-25.
22 Mazzaccaro D, Giannetta M, Fancoli F, et al. Covid and venous thrombosis: systematic review of literature. J Cardiovasc Surg. 2021;62(6):548-57.
23 Gabbai-Armelin PR, Oliveira AB, Ferrisse TM, et al. Covid-19 (SARS-CoV-2) infection and thrombotic conditions: a systematic review and meta-analysis. Eur J Clin Invest. 2021;51(6):e13559.
24 Roncon L, Zuin M, Barco S, et al. Incidence of acute pulmonary embolism in covid-19 patients: systematic review and meta-analysis. Eur J Intern Med. 2020;82(1):29-37.
25 Xiong X, Chi J, Gao Q. Prevalence and risk factors of thrombotic events on patients with covid-19: a systematic review and meta-analysis. Thromb J. 2021;19(1):32.
26 Longchamp G, Manzocchi-Besson S, Longchamp A, Righini M, Robert-Ebadi H, Blondon M. Proximal deep vein thrombosis and pulmonary embolism in covid-19 patients: a systematic review and meta-analysis. Thromb J. 2021;19(1):15.
27 Nopp S, Moik F, Jilma B, Pabinger I, Ay C. Risk of venous thromboembolism in patients with covid-19: a systematic review and meta-analysis. Res Pract Thromb Haemost. 2020;4(7):1178-91.
28 Jenner WJ, Kanji R, Mirsadraee S, et al. Thrombotic complications in 2928 patients with covid-19 treated in intensive care: a systematic review. J Thromb Thrombolysis. 2021;51(3):595-607.
29 Wu T, Zuo Z, Yang D, et al. Venous thromboembolic events in patients with covid-19: a systematic review and meta-analysis. Age Ageing. 2021;50(2):284-93.
30 Birkeland K, Zimmer R, Kimchi A, Kedan I. Venous thromboembolism in hospitalized covid-19 patients: systematic review. Interact J Med Res. 2020;9(3):e22768.
31 Mansory EM, Srigunapalan S, Lazo-Langner A. Venous thromboembolism in hospitalized critical and noncritical covid-19 patients: a systematic review and meta-analysis. TH Open. 2021;5(3):e286-94.
32 Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M. Venous thromboembolism in patients with covid-19: systematic review and meta-analysis. Thromb Res. 2020;196:67-74.
33 Zhang R, Ni L, Di X, et al. Systematic review and meta-analysis of the prevalence of venous thromboembolic events in novel coronavirus disease-2019 patients. J Vasc Surg Venous Lymphat Disord. 2021;9(2):289-98.e5.
34 Rossi FH. Tromboembolismo venoso em pacientes covid-19. J Vasc Bras. 2020;19:e20200107.
35 Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255-73.
36 Nascimento JHP, Gomes BFO, Carmo PR Jr, et al. Covid-19 e estado de hipercoagulabilidade: uma nova perspectiva terapêutica. Arq Bras Cardiol. 2020;114(5):829-33.
Submitted date:
06/20/2024
Accepted date:
10/29/2024
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email